key: cord-0756188-oryfe1w1 authors: Nauka, Peter C.; Oran, Erick; Chekuri, Sweta title: Deep venous thrombosis in a non-critically ill patient with novel COVID-19 infection date: 2020-05-14 journal: Thromb Res DOI: 10.1016/j.thromres.2020.05.015 sha: 9f70605b52ad16e8074dffbd30b2bd7c36a00809 doc_id: 756188 cord_uid: oryfe1w1 • COVID-19 infection is associated with hypercoagulability and a prothrombotic state. • Little is understood about the prevalence of venous thromboembolism in mild disease. • We present a case of mild COVID-19 complicated by extensive deep venous thrombosis. To the Editor: A 48-year-old non-smoker male with a history of coronary artery disease and non-heartbeating renal donation secondary to hypertensive nephrosclerosis was admitted to the medicine service with subjective fevers, myalgias, non-productive cough and dyspnea for two weeks. He denied recent travel or exposure to persons with known or suspected coronavirus disease 2019 . He had a temperature of 38.9C (102.1F), blood pressure of 187/110 mmHg, and oxygen saturation of 99% on room air. Physical examination was unremarkable except for a surgical scar in the right lower abdominal quadrant. Laboratory testing on admission was notable for leukopenia, thrombocytopenia, and elevated C-reactive protein and D-dimer (Table 1) . Polymerase chain reaction (PCR) testing for COVID-19 infection was positive. Chest x-ray demonstrated small patchy opacities in the mid-left lung field and electrocardiogram was remarkable for normal sinus rhythm with a QTc interval of 449 milliseconds. He was started on hydroxychloroquine for COVID-19, as well as azithromycin and ceftriaxone for communityacquired pneumonia. He received enoxaparin for deep vein thrombosis (DVT) prophylaxis. His symptoms improved, he did not require supplemental oxygen, and was discharged on hospital day two. He presented to the emergency room (ER) three days later with difficulty bearing weight on his right leg. Laboratory testing did not reveal significant changes from prior admission. He had normal range of motion, the leg did not appear erythematous or swollen on physical examination and he was discharged from the ER. The possibility of a deep venous thrombosis was not considered. Approximately two weeks after initial hospital admission, he returned to the ER with worsening right leg pain, erythema, and edema. Pain was sharp in nature, exacerbated by movement, ten out of ten on the numeric pain scale. Acetaminophen did not ameliorate the pain. He was afebrile and saturating 96% on room air. Physical examination was remarkable for erythema of the right leg from mid-calf to thigh and tenderness to palpation. Distal pulses were intact. He was found to have an elevated D-dimer, and COVID-19 PCR was positive again J o u r n a l P r e -p r o o f (Table 1) . Repeat chest x-ray was remarkable for worsening bilateral opacities. Duplex ultrasound of the right leg demonstrated an acute partially occlusive deep vein thrombosis within the common femoral and popliteal veins and acute occlusive clot in the gastrocnemius vein ( Figure 1) . He was started on therapeutic apixaban and IV vancomycin and ampicillin/sulbactam for possible overlying cellulitis. Further coagulation studies revealed a normal fibrinogen (313 mg/dL), and negative beta glycoprotein IgM/IgG, cardiolipin IgM/IgG and lupus anticoagulant. Erythema and pain improved, and he was discharged on apixaban for three months. [11] . Markers of thrombosis, such as elevation of D-dimer have been reported to correlate with disease severity, development of acute respiratory distress syndrome and mortality [12] [13] [14] [15] [16] [17] . Despite significant virulence and mortality associated with COVID-19 infection, 70-81% of patients undergo a mild course and require neither intensive care unit admission nor mechanical ventilation [18, 19] . Many of these patients are being treated on the general medical floors, and this case illustrates the importance of maintaining a high index of suspicion for thrombosis even in mild COVID-19 cases. Our patient required no supplemental oxygen, received standard DVT prophylaxis and had only a mild elevation of D-dimer on initial admission, but still subsequently developed a debilitating thrombosis. Given significant morbidity and mortality associated with VTE and tangible worldwide prevalence of COVID-19 infections, physicians should be aware of thrombotic complications even in mild cases. Further study is required to demonstrate the prevalence of VTE, appropriate screening metrics and need for ongoing VTE prophylaxis even after discharge for patients with mild COVID-19 disease. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection Acute pulmonary embolism and COVID-19 pneumonia: a random association? COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure COVID-19 and its implications for thrombosis and anticoagulation Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients ISTH interim guidance on recognition and management of coagulopathy in COVID-19 Acute limb ischemia in patients with COVID-19 pneumonia Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Clinical Characteristics of Coronavirus Disease 2019 in China Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention Coronavirus Disease 2019 (COVID-19) in Italy